

Granules Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 250.00 Cr
- Paid Up Capital ₹ 225.00 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 400.00 Cr
- Revenue Growth 71.69%
- Profit Growth -335.20%
- Ebitda -271.34%
- Net Worth 275.75%
- Total Assets 333.91%
About Granules Life Sciences
Granules Life Sciences Private Limited (GLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2020 (Four years and five months 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 250.00 Cr and a paid-up capital of Rs 225.00 Cr.
The company currently has active open charges totaling ₹400.00 Cr.
The Key Managerial Personnel (KMP) at Granules Life Sciences Private Limited India are Mukesh Surana as CFO and Anshuman Gupta as Company Secretary. Chigurupati Prasad, Umadevi Chigurupati, and Rajiv Kakodkar serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290TG2020PTC146042
- Company No.
146042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2020
- Date of AGM
27 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Granules Life Sciences?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mukesh Surana ![]() | CFO | 19-Apr-2024 | Current |
Anshuman Gupta | Company Secretary | 31-Mar-2021 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajiv Kakodkar ![]() | Additional Director | 19-Apr-2024 | Current |
Chigurupati Prasad ![]() | Director | 18-Nov-2020 | Current |
Umadevi Chigurupati ![]() | Additional Director | 19-Apr-2024 | Current |
Financial Performance of Granules Life Sciences.
Granules Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 71.69% increase. The company also saw a substantial fall in profitability, with a 335.2% decrease in profit. The company's net worth Soared by an impressive increase of 275.75%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Granules Life Sciences?
In 2024, Granules Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Krsma Vineyards Private Limited
Chigurupati Prasad and Umadevi Chigurupati are mutual person
- Krsma Estates Private Limited
Chigurupati Prasad and Umadevi Chigurupati are mutual person
- Vasundhara Rasayans Limited
Rajiv Kakodkar is a mutual person
- Granules India Limited
Chigurupati Prasad, Umadevi Chigurupati and 2 more are mutual person
- Triton Securities Llp
Chigurupati Prasad and Umadevi Chigurupati are mutual person
- Santhi Surgery Llp
Chigurupati Prasad is a mutual person
Charges (Loans)
₹400.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 400.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Feb 2024 | Sbicap Trustee Company Limited | ₹400.00 Cr | Open |
How Many Employees Work at Granules Life Sciences?
Unlock and access historical data on people associated with Granules Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Granules Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Granules Life Sciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Granules Life Sciences
Recent activity within the organization
- Director Appointment
Umadevi Chigurupati was appointed as a Additional Director was appointed as a Additional Director on 19 Apr 2024 & has been associated with this company since 1 year 20 days .
- Director Appointment
Rajiv Pritidas Kakodkar was appointed as a Additional Director was appointed as a Additional Director on 19 Apr 2024 & has been associated with this company since 1 year 20 days .
- Director Appointment
Mukesh Mahavirchand Surana was appointed as a Cfo was appointed as a Cfo on 19 Apr 2024 & has been associated with this company since 1 year 20 days .
- Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 400.00 Cr with Charge ID 100880384 was registered on 20 Feb 2024.
- Annual General Meeting
Granules Life Sciences Private Limited last Annual general meeting of members was held on 27 Jul 2023 as per latest MCA records.
- Balance Sheet
Granules Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Recent News, Updates & Announcement
- Granules India Q3 FY24 Results Live : profit rise by 1.06% YOY | Mint.
Granules India Q3 FY24 Results Live : Revenue increased by 0.83% YoY & profit increasedby 1.06% YoY.
- Granules India Reports Mixed Q2 FY24 Results, Analysts Recommend Strong Buy.
Granules India's Q2 FY24 results showed a 3.37% increase in revenue but a 29.62% decrease in profit compared to last year. However, compared to the previous quarter, there was significant growth in revenue and profit. Operating income increased by 83.2% but decreased by 19.31% compared to last year. EPS for Q2 FY24 is ₹4.22, a 27.49% decrease from last year. The company has delivered good returns and has a Strong Buy recommendation from analysts. Keep up with their results on our calendar..
- Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn.
Granules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release capsules. The capsules are used for the short-term treatment of heartburn and other symptoms of gastroesophageal reflux disease. The approval is for capsules with strengths of 20 mg and 40 mg, and they are bioequivalent and therapeutically equivalent to the reference drug, Nexium..
Frequently asked questions
What is the Incorporation or founding date of Granules Life Sciences Private Limited?
Granules Life Sciences Private Limited was incorporated on 18 Nov 2020.
What is authorized share capital and paid-up capital of Granules Life Sciences Private Limited?
The authorized share capital of Granules Life Sciences Private Limited is ₹ 250.00 Cr and paid-up capital is ₹ 225.00 Cr.
Who are the current board members & directors of Granules Life Sciences Private Limited?
Currently 5 directors are associated with Granules Life Sciences Private Limited.
- Chigurupati Krishna Prasad
- Umadevi Chigurupati
- Rajiv Pritidas Kakodkar
- Mukesh Mahavirchand Surana
- Anshuman Gupta
What is the registered address of Granules Life Sciences Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Granules Life Sciences Private Limited is Iind Floor, 3Rd Block My Home Hub Madhapur India, Hyderabad, Telangana, 500081.
What is the corporate identification number (CIN) and company number of Granules Life Sciences Private Limited?
The corporate identification number (CIN) of Granules Life Sciences Private Limited is U24290TG2020PTC146042 and the company number is 146042 as per Ministry of Corporate Affairs (MCA).
What is the official website of Granules Life Sciences Private Limited?
The Official website of Granules Life Sciences Private Limited is https://www.granulesindia.com
What has been the recent revenue trend for Granules Life Sciences Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Granules Life Sciences Private Limited has risen by 71.69%.
What change has been observed in the net worth of Granules Life Sciences Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Granules Life Sciences Private Limited has experienced an upsurge of 275.75%.
What are the total open charges for Granules Life Sciences Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Granules Life Sciences Private Limited amount to ₹ 400.00 Cr.
When was the last Balance Sheet of Granules Life Sciences Private Limited filed with the ROC?
The most recent Balance Sheet for Granules Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
PC
Priyanka ChigurupatiDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India